1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hereditary Cancer Testing Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 RNA Testing 1.2.3 DNA Testing 1.3 Market by Application 1.3.1 Global Hereditary Cancer Testing Market Share by Application: 2020 VS 2026 1.3.2 Breast Cancer 1.3.3 Gastrointestinal Cancer 1.3.4 Prostate Cancer 1.3.5 Respiratory/Lung Cancer 1.3.6 Other Cancers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hereditary Cancer Testing Market Perspective (2015-2026) 2.2 Global Hereditary Cancer Testing Growth Trends by Regions 2.2.1 Hereditary Cancer Testing Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Hereditary Cancer Testing Historic Market Share by Regions (2015-2020) 2.2.3 Hereditary Cancer Testing Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hereditary Cancer Testing Players by Market Size 3.1.1 Global Top Hereditary Cancer Testing Players by Revenue (2015-2020) 3.1.2 Global Hereditary Cancer Testing Revenue Market Share by Players (2015-2020) 3.2 Global Hereditary Cancer Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Hereditary Cancer Testing Revenue 3.4 Global Hereditary Cancer Testing Market Concentration Ratio 3.4.1 Global Hereditary Cancer Testing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hereditary Cancer Testing Revenue in 2019 3.5 Key Players Hereditary Cancer Testing Area Served 3.6 Key Players Hereditary Cancer Testing Product Solution and Service 3.7 Date of Enter into Hereditary Cancer Testing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hereditary Cancer Testing Breakdown Data by Type (2015-2026) 4.1 Global Hereditary Cancer Testing Historic Market Size by Type (2015-2020) 4.2 Global Hereditary Cancer Testing Forecasted Market Size by Type (2021-2026) 5 Hereditary Cancer Testing Breakdown Data by Application (2015-2026) 5.1 Global Hereditary Cancer Testing Historic Market Size by Application (2015-2020) 5.2 Global Hereditary Cancer Testing Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Hereditary Cancer Testing Market Size (2015-2026) 6.2 North America Hereditary Cancer Testing Market Size by Type (2015-2020) 6.3 North America Hereditary Cancer Testing Market Size by Application (2015-2020) 6.4 North America Hereditary Cancer Testing Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Hereditary Cancer Testing Market Size (2015-2026) 7.2 Europe Hereditary Cancer Testing Market Size by Type (2015-2020) 7.3 Europe Hereditary Cancer Testing Market Size by Application (2015-2020) 7.4 Europe Hereditary Cancer Testing Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Hereditary Cancer Testing Market Size (2015-2026) 8.2 China Hereditary Cancer Testing Market Size by Type (2015-2020) 8.3 China Hereditary Cancer Testing Market Size by Application (2015-2020) 8.4 China Hereditary Cancer Testing Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Hereditary Cancer Testing Market Size (2015-2026) 9.2 Japan Hereditary Cancer Testing Market Size by Type (2015-2020) 9.3 Japan Hereditary Cancer Testing Market Size by Application (2015-2020) 9.4 Japan Hereditary Cancer Testing Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Hereditary Cancer Testing Market Size (2015-2026) 10.2 Southeast Asia Hereditary Cancer Testing Market Size by Type (2015-2020) 10.3 Southeast Asia Hereditary Cancer Testing Market Size by Application (2015-2020) 10.4 Southeast Asia Hereditary Cancer Testing Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Ambry Genetics (Konica Minota) 11.1.1 Ambry Genetics (Konica Minota) Company Details 11.1.2 Ambry Genetics (Konica Minota) Business Overview 11.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Introduction 11.1.4 Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2015-2020)) 11.1.5 Ambry Genetics (Konica Minota) Recent Development 11.2 Asper Biogene 11.2.1 Asper Biogene Company Details 11.2.2 Asper Biogene Business Overview 11.2.3 Asper Biogene Hereditary Cancer Testing Introduction 11.2.4 Asper Biogene Revenue in Hereditary Cancer Testing Business (2015-2020) 11.2.5 Asper Biogene Recent Development 11.3 Natera 11.3.1 Natera Company Details 11.3.2 Natera Business Overview 11.3.3 Natera Hereditary Cancer Testing Introduction 11.3.4 Natera Revenue in Hereditary Cancer Testing Business (2015-2020) 11.3.5 Natera Recent Development 11.4 Caris Life Sciences 11.4.1 Caris Life Sciences Company Details 11.4.2 Caris Life Sciences Business Overview 11.4.3 Caris Life Sciences Hereditary Cancer Testing Introduction 11.4.4 Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020) 11.4.5 Caris Life Sciences Recent Development 11.5 BioReference Laboratories (GeneDx) 11.5.1 BioReference Laboratories (GeneDx) Company Details 11.5.2 BioReference Laboratories (GeneDx) Business Overview 11.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Introduction 11.5.4 BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2015-2020) 11.5.5 BioReference Laboratories (GeneDx) Recent Development 11.6 LabSolutions 11.6.1 LabSolutions Company Details 11.6.2 LabSolutions Business Overview 11.6.3 LabSolutions Hereditary Cancer Testing Introduction 11.6.4 LabSolutions Revenue in Hereditary Cancer Testing Business (2015-2020) 11.6.5 LabSolutions Recent Development 11.7 Progenity，Inc 11.7.1 Progenity，Inc Company Details 11.7.2 Progenity，Inc Business Overview 11.7.3 Progenity，Inc Hereditary Cancer Testing Introduction 11.7.4 Progenity，Inc Revenue in Hereditary Cancer Testing Business (2015-2020) 11.7.5 Progenity，Inc Recent Development 11.8 ARUP Laboratories 11.8.1 ARUP Laboratories Company Details 11.8.2 ARUP Laboratories Business Overview 11.8.3 ARUP Laboratories Hereditary Cancer Testing Introduction 11.8.4 ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2015-2020) 11.8.5 ARUP Laboratories Recent Development 11.9 NeoGenomics 11.9.1 NeoGenomics Company Details 11.9.2 NeoGenomics Business Overview 11.9.3 NeoGenomics Hereditary Cancer Testing Introduction 11.9.4 NeoGenomics Revenue in Hereditary Cancer Testing Business (2015-2020) 11.9.5 NeoGenomics Recent Development 11.10 Blueprint Genetics 11.10.1 Blueprint Genetics Company Details 11.10.2 Blueprint Genetics Business Overview 11.10.3 Blueprint Genetics Hereditary Cancer Testing Introduction 11.10.4 Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2015-2020) 11.10.5 Blueprint Genetics Recent Development 11.11 CellMax Life 10.11.1 CellMax Life Company Details 10.11.2 CellMax Life Business Overview 10.11.3 CellMax Life Hereditary Cancer Testing Introduction 10.11.4 CellMax Life Revenue in Hereditary Cancer Testing Business (2015-2020) 10.11.5 CellMax Life Recent Development 11.12 Fulgent Genetics 10.12.1 Fulgent Genetics Company Details 10.12.2 Fulgent Genetics Business Overview 10.12.3 Fulgent Genetics Hereditary Cancer Testing Introduction 10.12.4 Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2015-2020) 10.12.5 Fulgent Genetics Recent Development 11.13 Myriad Genetics 10.13.1 Myriad Genetics Company Details 10.13.2 Myriad Genetics Business Overview 10.13.3 Myriad Genetics Hereditary Cancer Testing Introduction 10.13.4 Myriad Genetics Revenue in Hereditary Cancer Testing Business (2015-2020) 10.13.5 Myriad Genetics Recent Development 11.14 Myogenes 10.14.1 Myogenes Company Details 10.14.2 Myogenes Business Overview 10.14.3 Myogenes Hereditary Cancer Testing Introduction 10.14.4 Myogenes Revenue in Hereditary Cancer Testing Business (2015-2020) 10.14.5 Myogenes Recent Development 11.15 LabCorp 10.15.1 LabCorp Company Details 10.15.2 LabCorp Business Overview 10.15.3 LabCorp Hereditary Cancer Testing Introduction 10.15.4 LabCorp Revenue in Hereditary Cancer Testing Business (2015-2020) 10.15.5 LabCorp Recent Development 11.16 Quest Diagnostics 10.16.1 Quest Diagnostics Company Details 10.16.2 Quest Diagnostics Business Overview 10.16.3 Quest Diagnostics Hereditary Cancer Testing Introduction 10.16.4 Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2015-2020) 10.16.5 Quest Diagnostics Recent Development 11.17 Pathway Genomics 10.17.1 Pathway Genomics Company Details 10.17.2 Pathway Genomics Business Overview 10.17.3 Pathway Genomics Hereditary Cancer Testing Introduction 10.17.4 Pathway Genomics Revenue in Hereditary Cancer Testing Business (2015-2020) 10.17.5 Pathway Genomics Recent Development 11.18 Strand Life Sciences 10.18.1 Strand Life Sciences Company Details 10.18.2 Strand Life Sciences Business Overview 10.18.3 Strand Life Sciences Hereditary Cancer Testing Introduction 10.18.4 Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020) 10.18.5 Strand Life Sciences Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hereditary Cancer Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of RNA Testing Table 4. Key Players of DNA Testing Table 5. Global Hereditary Cancer Testing Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 6. Global Hereditary Cancer Testing Market Size by Regions (US$ Million): 2020 VS 2026 Table 7. Global Hereditary Cancer Testing Market Size by Regions (2015-2020) (US$ Million) Table 8. Global Hereditary Cancer Testing Market Share by Regions (2015-2020) Table 9. Global Hereditary Cancer Testing Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 10. Global Hereditary Cancer Testing Market Share by Regions (2021-2026) Table 11. Hereditary Cancer Testing Market Market Trends Table 12. Hereditary Cancer Testing Market Drivers Table 13. Hereditary Cancer Testing Market Challenges Table 14. Hereditary Cancer Testing Market Restraints Table 15. Global Hereditary Cancer Testing Revenue by Players (2015-2020) (US$ Million) Table 16. Global Hereditary Cancer Testing Market Share by Players (2015-2020) Table 17. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Cancer Testing as of 2019) Table 18. Global Hereditary Cancer Testing by Players Market Concentration Ratio (CR5 and HHI) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Hereditary Cancer Testing Product Solution and Service Table 21. Mergers & Acquisitions, Expansion Plans Table 22. Global Hereditary Cancer Testing Market Size by Type (2015-2020) (US$ Million) Table 23. Global Hereditary Cancer Testing Market Size Share by Type (2015-2020) Table 24. Global Hereditary Cancer Testing Revenue Market Share by Type (2021-2026) Table 25. Global Hereditary Cancer Testing Market Size Share by Application (2015-2020) Table 26. Global Hereditary Cancer Testing Market Size by Application (2015-2020) (US$ Million) Table 27. Global Hereditary Cancer Testing Market Size Share by Application (2021-2026) Table 28. North America Hereditary Cancer Testing Market Size by Type (2015-2020) (US$ Million) Table 29. North America Hereditary Cancer Testing Market Share by Type (2015-2020) Table 30. North America Hereditary Cancer Testing Market Size by Application (2015-2020) (US$ Million) Table 31. North America Hereditary Cancer Testing Market Share by Application (2015-2020) Table 32. North America Hereditary Cancer Testing Market Size by Country (US$ Million) (2015-2020) Table 33. North America Hereditary Cancer Testing Market Share by Country (2015-2020) Table 34. Europe Hereditary Cancer Testing Market Size by Type (2015-2020) (US$ Million) Table 35. Europe Hereditary Cancer Testing Market Share by Type (2015-2020) Table 36. Europe Hereditary Cancer Testing Market Size by Application (2015-2020) (US$ Million) Table 37. Europe Hereditary Cancer Testing Market Share by Application (2015-2020) Table 38. Europe Hereditary Cancer Testing Market Size by Country (US$ Million) (2015-2020) Table 39. Europe Hereditary Cancer Testing Market Share by Country (2015-2020) Table 40. China Hereditary Cancer Testing Market Size by Type (2015-2020) (US$ Million) Table 41. China Hereditary Cancer Testing Market Share by Type (2015-2020) Table 42. China Hereditary Cancer Testing Market Size by Application (2015-2020) (US$ Million) Table 43. China Hereditary Cancer Testing Market Share by Application (2015-2020) Table 44. China Hereditary Cancer Testing Market Size by Region (US$ Million) (2015-2020) Table 45. China Hereditary Cancer Testing Market Share by Region (2015-2020) Table 46. Japan Hereditary Cancer Testing Market Size by Type (2015-2020) (US$ Million) Table 47. Japan Hereditary Cancer Testing Market Share by Type (2015-2020) Table 48. Japan Hereditary Cancer Testing Market Size by Application (2015-2020) (US$ Million) Table 49. Japan Hereditary Cancer Testing Market Share by Application (2015-2020) Table 50. Japan Hereditary Cancer Testing Market Size by Country (US$ Million) (2015-2020) Table 51. Japan Hereditary Cancer Testing Market Share by Country (2015-2020) Table 52. Southeast Asia Hereditary Cancer Testing Market Size by Type (2015-2020) (US$ Million) Table 53. Southeast Asia Hereditary Cancer Testing Market Share by Type (2015-2020) Table 54. Southeast Asia Hereditary Cancer Testing Market Size by Application (2015-2020) (US$ Million) Table 55. Southeast Asia Hereditary Cancer Testing Market Share by Application (2015-2020) Table 56. Southeast Asia Hereditary Cancer Testing Market Size by Country (US$ Million) (2015-2020) Table 57. Southeast Asia Hereditary Cancer Testing Market Share by Country (2015-2020) Table 58. Ambry Genetics (Konica Minota) Company Details Table 59. Ambry Genetics (Konica Minota) Business Overview Table 60. Ambry Genetics (Konica Minota) Product Table 61. Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million) Table 62. Ambry Genetics (Konica Minota) Recent Development Table 63. Asper Biogene Company Details Table 64. Asper Biogene Business Overview Table 65. Asper Biogene Product Table 66. Asper Biogene Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million) Table 67. Asper Biogene Recent Development Table 68. Natera Company Details Table 69. Natera Business Overview Table 70. Natera Product Table 71. Natera Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million) Table 72. Natera Recent Development Table 73. Caris Life Sciences Company Details Table 74. Caris Life Sciences Business Overview Table 75. Caris Life Sciences Product Table 76. Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million) Table 77. Caris Life Sciences Recent Development Table 78. BioReference Laboratories (GeneDx) Company Details Table 79. BioReference Laboratories (GeneDx) Business Overview Table 80. BioReference Laboratories (GeneDx) Product Table 81. BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million) Table 82. BioReference Laboratories (GeneDx) Recent Development Table 83. LabSolutions Company Details Table 84. LabSolutions Business Overview Table 85. LabSolutions Product Table 86. LabSolutions Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million) Table 87. LabSolutions Recent Development Table 88. Progenity，Inc Company Details Table 89. Progenity，Inc Business Overview Table 90. Progenity，Inc Product Table 91. Progenity，Inc Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million) Table 92. Progenity，Inc Recent Development Table 93. ARUP Laboratories Business Overview Table 94. ARUP Laboratories Product Table 95. ARUP Laboratories Company Details Table 96. ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million) Table 97. ARUP Laboratories Recent Development Table 98. NeoGenomics Company Details Table 99. NeoGenomics Business Overview Table 100. NeoGenomics Product Table 101. NeoGenomics Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million) Table 102. NeoGenomics Recent Development Table 103. Blueprint Genetics Company Details Table 104. Blueprint Genetics Business Overview Table 105. Blueprint Genetics Product Table 106. Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million) Table 107. Blueprint Genetics Recent Development Table 108. CellMax Life Company Details Table 109. CellMax Life Business Overview Table 110. CellMax Life Product Table 111. CellMax Life Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million) Table 112. CellMax Life Recent Development Table 113. Fulgent Genetics Company Details Table 114. Fulgent Genetics Business Overview Table 115. Fulgent Genetics Product Table 116. Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million) Table 117. Fulgent Genetics Recent Development Table 118. Myriad Genetics Company Details Table 119. Myriad Genetics Business Overview Table 120. Myriad Genetics Product Table 121. Myriad Genetics Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million) Table 122. Myriad Genetics Recent Development Table 123. Myogenes Company Details Table 124. Myogenes Business Overview Table 125. Myogenes Product Table 126. Myogenes Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million) Table 127. Myogenes Recent Development Table 128. LabCorp Company Details Table 129. LabCorp Business Overview Table 130. LabCorp Product Table 131. LabCorp Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million) Table 132. LabCorp Recent Development Table 133. Quest Diagnostics Company Details Table 134. Quest Diagnostics Business Overview Table 135. Quest Diagnostics Product Table 136. Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million) Table 137. Quest Diagnostics Recent Development Table 138. Pathway Genomics Company Details Table 139. Pathway Genomics Business Overview Table 140. Pathway Genomics Product Table 141. Pathway Genomics Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million) Table 142. Pathway Genomics Recent Development Table 143. Strand Life Sciences Company Details Table 144. Strand Life Sciences Business Overview Table 145. Strand Life Sciences Product Table 146. Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2015-2020) (US$ Million) Table 147. Strand Life Sciences Recent Development Table 148. Research Programs/Design for This Report Table 149. Key Data Information from Secondary Sources Table 150. Key Data Information from Primary Sources List of Figures Figure 1. Global Hereditary Cancer Testing Market Share by Type: 2020 VS 2026 Figure 2. RNA Testing Features Figure 3. DNA Testing Features Figure 4. Global Hereditary Cancer Testing Market Share by Application: 2020 VS 2026 Figure 5. Breast Cancer Case Studies Figure 6. Gastrointestinal Cancer Case Studies Figure 7. Prostate Cancer Case Studies Figure 8. Respiratory/Lung Cancer Case Studies Figure 9. Other Cancers Case Studies Figure 10. Hereditary Cancer Testing Report Years Considered Figure 11. Global Hereditary Cancer Testing Market Size (US$ Million), YoY Growth 2015-2026 Figure 12. Global Hereditary Cancer Testing Market Share by Regions: 2020 VS 2026 Figure 13. Global Hereditary Cancer Testing Market Share by Regions (2021-2026) Figure 14. Global Hereditary Cancer Testing Market Share by Players in 2019 Figure 15. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Cancer Testing as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Hereditary Cancer Testing Revenue in 2019 Figure 17. North America Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 18. United States Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 19. Canada Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. Europe Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. Germany Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. France Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. U.K. Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Italy Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Russia Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Nordic Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Rest of Europe Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Asia-Pacific Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. China Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Japan Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. South Korea Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Southeast Asia Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. India Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Australia Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Rest of Asia-Pacific Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Latin America Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Mexico Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Brazil Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Middle East & Africa Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Turkey Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Saudi Arabia Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. UAE Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Rest of Middle East & Africa Hereditary Cancer Testing Market Size YoY Growth (2015-2026) & (US$ Million) Figure 44. Ambry Genetics (Konica Minota) Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020) Figure 45. Asper Biogene Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020) Figure 46. Natera Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020) Figure 47. Caris Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020) Figure 48. BioReference Laboratories (GeneDx) Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020) Figure 49. LabSolutions Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020) Figure 50. Progenity，Inc Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020) Figure 51. ARUP Laboratories Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020) Figure 52. NeoGenomics Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020) Figure 53. Blueprint Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020) Figure 54. CellMax Life Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020) Figure 55. Fulgent Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020) Figure 56. Myriad Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020) Figure 57. Myogenes Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020) Figure 58. LabCorp Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020) Figure 59. Quest Diagnostics Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020) Figure 60. Pathway Genomics Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020) Figure 61. Strand Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2015-2020) Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed

Ambry Genetics (Konica Minota) Asper Biogene Natera Caris Life Sciences BioReference Laboratories (GeneDx) LabSolutions Progenity，Inc ARUP Laboratories NeoGenomics Blueprint Genetics CellMax Life Fulgent Genetics Myriad Genetics Myogenes LabCorp Quest Diagnostics Pathway Genomics Strand Life Sciences